Abstract
Metabolic syndrome is a cluster of symptoms including excessive body fat and insulin resistance which may lead to obesity and type 2 diabetes (T2D). The physiological and pathological cross-talk between T2D and obesity is crucial and complex, meanwhile, the genetic connection between T2D and obesity is largely unknown. The purpose of this study is to identify pleiotropic SNPs and genes between these two associated conditions by applying genetic analysis incorporating pleiotropy and annotation (GPA) on two large genome-wide association studies (GWAS) data sets: a body mass index (BMI) data set containing 339,224 subjects and a T2D data set containing 110,452 subjects. In all, 5182 SNPs showed pleiotropy in both T2D and obesity. After further prioritization based on suggested local false discovery rates (FDR) by the GPA model, 2146 SNPs corresponding to 217 unique genes are significantly associated with both traits (FDR < 0.2), among which 187 are newly identified pleiotropic genes compare with original GWAS in individual traits. Subsequently, gene enrichment and pathway analyses highlighted several pleiotropic SNPs including rs849135 (FDR = 0.0002), rs2119812 (FDR = 0.0018), rs4506565 (FDR = 1.23E−08), rs1558902 (7.23E−10) and corresponding genes JAZF1, SYN2, TCF7L2, FTO which may play crucial rol5es in the etiology of both T2D and obesity. Additional evidences from expression data analysis of pleiotropic genes strongly supports that the pleiotropic genes including JAZF1 (p = 1.39E−05 and p = 2.13E−05), SYN2 (p = 5.49E−03 and p = 5.27E−04), CDKN2C (p = 1.99E−12 and p = 6.27E−11), RABGAP1 (p = 3.08E−03 and p = 7.46E−03), and UBE2E2 (p = 1.83E−04 and p = 8.22E−03) play crucial roles in both obesity and T2D pathogenesis. Pleiotropic analysis integrated with functional network identified several novel and causal SNPs and genes involved in both BMI and T2D which may be ignored in single GWAS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fall T, Ingelsson E. Genome-wide association studies of obesity and metabolic syndrome. Mol Cell Endocrinol. 2014;382:740–57.
Min JL, Nicholson G, Halgrimsdottir I, Almstrup K, Petri A, Barrett A, et al. Coexpression network analysis in abdominal and gluteal adipose tissue reveals regulatory genetic loci for metabolic syndrome and related phenotypes. PLoS Genet. 2012;8:e1002505.
Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162.
Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP. The prevalence of metabolic syndrome in various populations. Am J Med Sci. 2007;333:362–71.
Desroches S, Lamarche B. The evolving definitions and increasing prevalence of the metabolic syndrome. Appl Physiol Nutr Metab. 2007;32:23–32.
Lim SS, Vos T, Flaxman AD. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 (vol 380, pg 2224, 2012). Lancet. 2013;381:1276.
Prospective Studies C, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.
Horr S, Nissen S. Managing hypertension in type 2 diabetes mellitus. Best practice & research. Clin Endocrinol Metab. 2016;30:445–54.
Winnier DA, Fourcaudot M, Norton L, Abdul-Ghani MA, Hu SL, Farook VS, et al. Transcriptomic identification of ADH1B as a novel candidate gene for obesity and insulin resistance in human adipose tissue in Mexican Americans from the Veterans Administration Genetic Epidemiology Study (VAGES). Plos ONE. 2015;10:e0119941
Bastien M, Poirier P, Lemieux I, Despres JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56:369–81.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14.
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7.
Kogelman LJ, Zhernakova DV, Westra HJ, Cirera S, Fredholm M, Franke L, et al. An integrative systems genetics approach reveals potential causal genes and pathways related to obesity. Genome Med. 2015;7:105.
Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197–206.
Mahajan A, Go MJ, Zhang WH, Below JE, Gaulton KJ, Ferreira T, et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014;46:234.
Chung D, Yang C, Li C, Gelernter J, Zhao H. GPA: a statistical approach to prioritizing GWAS results by integrating pleiotropy and annotation. PLoS Genet. 2014;10:e1004787.
Stearns FW. One hundred years of pleiotropy: a retrospective. Genetics. 2010;186:767–73.
Paaby AB, Rockman MV. The many faces of pleiotropy. Trends Genet. 2013;29:66–73.
Swa HL, Shaik AA, Lim LH, Gunaratne J. Mass spectrometry based quantitative proteomics and integrative network analysis accentuates modulating roles of annexin-1 in mammary tumorigenesis. Proteomics. 2015;15:408–18.
Wu X, Hasan MA, Chen JY. Pathway and network analysis in proteomics. J Theor Biol. 2014;362:44–52.
Sherman BT, Huang da W, Tan Q, Guo Y, Bour S, Liu D, et al. DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinforma. 2007;8:426.
Zeng Y, Zhang L, Zhu W, Xu C, He H, Zhou Y, et al. Quantitative proteomics and integrative network analysis identified novel genes and pathways related to osteoporosis. J Proteom. 2016;142:45–52.
Zhang L, Liu YZ, Zeng Y, Zhu W, Zhao YC, Zhang JG, et al. Network-based proteomic analysis for postmenopausal osteoporosis in caucasian females. Proteomics. 2016;16:12–28
Stancakova A, Civelek M, Saleem NK, Soininen P, Kangas AJ, Cederberg H, et al. Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes 2012;61:1895–902.
Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol. 2012;8:228–36.
Huang T, Qi Q, Zheng Y, Ley SH, Manson JE, Hu FB, et al. Genetic predisposition to central obesity and risk of type 2 diabetes: two independent cohort studies. Diabetes Care. 2015;38:1306–11.
Blakemore AI, Buxton JL. Obesity, genetic risk, and environment. BMJ. 2014;348:g1900.
Vattikuti S, Guo J, Chow CC. Heritability and genetic correlations explained by common SNPs for metabolic syndrome traits. PLoS Genet. 2012;8:e1002637.
McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363:2339–50.
Zhu X, Feng T, Tayo BO, Liang J, Young JH, Franceschini N, et al. Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension. Am J Hum Genet. 2015;96:21–36.
Andreassen OA, Thompson WK, Schork AJ, Ripke S, Mattingsdal M, Kelsoe JR, et al. Correction: improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet. 2015;11:e1005544.
Corvin A, Craddock N, Sullivan PF. Genome-wide association studies: a primer. Psychol Med. 2010;40:1063–77.
Korte A, Farlow A. The advantages and limitations of trait analysis with GWAS: a review. Plant Methods. 2013;9:29.
Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R, et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci. 2014;17:1418–28.
Consortium GT. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348:648–60.
Langberg KA, Ma L, Sharma NK, Hanis CL, Elbein SC, Hasstedt SJ, et al. Single nucleotide polymorphisms in JAZF1 and BCL11A gene are nominally associated with type 2 diabetes in African-American families from the GENNID study. J Hum Genet. 2012;57:57–61.
Schleinitz D, Tonjes A, Bottcher Y, Dietrich K, Enigk B, Koriath M, et al. Lack of significant effects of the type 2 diabetes susceptibility loci JAZF1, CDC123/CAMK1D, NOTCH2, ADAMTS9, THADA, and TSPAN8/LGR5 on diabetes and quantitative metabolic traits. Horm Metab Res. 2010;42:14–22.
Stevens VL, Ahn J, Sun J, Jacobs EJ, Moore SC, Patel AV, et al. HNF1B and JAZF1 genes, diabetes, and prostate cancer risk. Prostate. 2010;70:601–7.
Jang WY, Bae KB, Kim SH, Yu DH, Kim HJ, Ji YR, et al. Overexpression of Jazf1 reduces body weight gain and regulates lipid metabolism in high fat diet. Biochem Biophys Res Commun. 2014;444:296–301.
Ming GF, Xiao D, Gong WJ, Liu HX, Liu J, Zhou HH, et al. JAZF1 can regulate the expression of lipid metabolic genes and inhibit lipid accumulation in adipocytes. Biochem Bioph Res Commun. 2014;445:673–80.
Li L, Yang Y, Yang GY, Lu CM, Yang ML, Liu H, et al. The role of JAZF1 on lipid metabolism and related genes in vitro. Metabolism. 2011;60:523–30.
Sharma NK, Langberg KA, Mondal AK, Elbein SC, Das SK. Type 2 diabetes (T2D) associated polymorphisms regulate expression of adjacent transcripts in transformed lymphocytes, adipose, and muscle from Caucasian and African-American subjects. J Clin Endocrinol Metab. 2011;96:E394–403.
Popa E, Rusu A, Purcarea C. Methanobrevibacter smithii carbamoyl phosphate synthetase, a missing link and a putative target for obesity prevention. Curr Opin Biotech. 2011;22:S81.
Rodriguez-Acebes S, Palacios N, Botella-Carretero JI, Olea N, Crespo L, Peromingo R, et al. Gene expression profiling of subcutaneous adipose tissue in morbid obesity using a focused microarray: distinct expression of cell-cycle- and differentiation-related genes. BMC Med Genomics. 2010;3:61.
Zhao Y, Shi K, Su X, Xie L, Yan Y. Microcystin-LR induces dysfunction of insulin secretion in rat insulinoma (INS-1) cells: implications for diabetes mellitus. J Hazard Mater. 2016;314:11–21.
Claussnitzer M, Dankel SN, Kim KH, Quon G, Meuleman W, Haugen C, et al. FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med. 2015;373:895–907.
Jia GF, Fu Y, Zhao X, Dai Q, Zheng GQ, Yang Y, et al. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO (vol 7, pg 885, 2011). Nat Chem Biol. 2012;8:1008.
Wang TL, Hong TT, Huang Y, Su HM, Wu F, Chen Y, et al. Fluorescein derivatives as bifunctional molecules for the simultaneous inhibiting and labeling of FTO protein. J Am Chem Soc. 2015;137:13736–9.
Chen X, Ayala I, Shannon C, Fourcaudot M, Acharya NK, Jenkinson CP, et al. The diabetes gene and wnt pathway effector TCF7L2 regulates adipocyte development and function. Diabetes. 2018;67:554–68.
Acknowledgements
We thank our laboratory members for the collaboration and helpful discussion.
Funding
This study was partially supported by grants from NIH (R01AR059781 and R01MH104680) and Edward G. Schlieder Endowment. The study also benefited from the National Natural Science Foundation of China (31371194) and the Fundamental Research Funds from the Central Universities (2013JBM098).
Author information
Authors and Affiliations
Contributions
HWD and YZ conceived the idea and designed the study. YZ performed GPA analysis. YZ, HH, LZ, WZ and HS participated in data manipulation or data analysis. YZ and HWD wrote and revised the paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zeng, Y., He, H., Zhang, L. et al. GWA-based pleiotropic analysis identified potential SNPs and genes related to type 2 diabetes and obesity. J Hum Genet 66, 297–306 (2021). https://doi.org/10.1038/s10038-020-00843-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s10038-020-00843-4
This article is cited by
-
E-GWAS: an ensemble-like GWAS strategy that provides effective control over false positive rates without decreasing true positives
Genetics Selection Evolution (2023)
-
Genome-wide association study reveals novel loci associated with feeding behavior in Pekin ducks
BMC Genomics (2021)